Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage.
- 15 December 1998
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 54 (9) , 697-699
- https://doi.org/10.1007/s002280050537
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: